S3
under reduced pressure to give pure (S,R S )-4 (0.110 g, 95%, de 99.7%) as white solid, m.p. 82-83 °С.
[α] D 25 = 57.2 (C 1, CHCl 3 ). The isomers ratio was determined by chiral HPLC of N-Cbz-derivative (S)-5 to be 99.85:0.15 (described below); major (S)-isomer peak -6.5 min; minor (R)-isomer peak -8.5
min. Column Chiralpak AD, eluent n-C 6 H 14 /iPrOH = 85:15, rate 1 mL/ min, UV 219 nm. R f = 0.54 (n- 
b) In-mediated allylation of (S S )-3:
A mixture of In turnings (1.29 g, 11.22 mmol) and AllylBr (1.36 g, 0.97 mL, 11.22 mmol) was refluxed in THF (7 mL) for 30 min. It was cooled to room temperature and 30a (1.00 g, 3.74 ммоль) dissolved in THF (1 mL) was added. The reaction mixture was stirred for 18 h at room temperature, quenched with satd. NH 4 Cl (15 mL) and diluted with Et 2 O. The organic layer was washed with brine and Na 2 -EDTA solution, dried over Na 2 SO 4 and evaporated under reduced pressure to dryness to give (S,R S )-4 (1.16 g, quant., de 97.1 %). The isomers ratio was determined by chiral HPLC of N-Cbz-derivative (S)-5 to be 98.57:1.43 retention times: major (S)-isomer peak -6.5 min; minor (R)-isomer peak -8.5 min.
Column Chiralpak AD, eluent n-C 6 H 14 /iPrOH = 85:15, rate 1 mL/ min, UV 219 nm.
(S S )-N-((1R)-1-(adamantan-1-yl)but-3-en-1-yl)-2-methylpropane-2-sulfinamide ((R,S S )-4).
The isomers ratio was determined by chiral HPLC of N-Cbz-derivative (R)-5 to be 99.35:0.65 (described below); minor (S)-isomer peak -6.5 min; major (R)-isomer peak -9.0 min. The isomers ratio was determined by chiral HPLC of N-Cbz-derivative (R)-5 to be 99.35:0.65 (described below); minor (S)-isomer peak -6.5 min; major (R)-isomer peak -9.0 min.
Synthesis of adamantyl derivatives 6, 7, rac-5 for chiral HPLC.
N-[1-(Adamantan-1-yl)methylyden]-2-methyl-2-propanesulfonamide (6).
Commercial m-CPBA 70% (1.0 g) was dissolved in DCM and dried with Na 2 SO 4 , then carefully decanted from drying agent and evaporated to dryness on the Rotavapor. The dry m-CPBA (0.13 g, 0.56 mmol) was added to a solution of the sulfinylimine (R S )-3 (0.15 g, 0.56 mmol) in DCM (4 mL) at room temperature. The reaction was completed in 1 min (TLC control). The mixture was diluted with DCM
S4
(12 mL) and washed with a saturated solution of NaHCO 3 (3x6 mL). The organic phase was dried over Na 2 SO 4 , and the solvent was evaporated to give crude sulfonylimine 6 (0.103 g, 97%) which was used further without purification. Sulfonylimine 6 is partially hydrolysed during isolation and chromatography, however, for analythical purposes small amount of 6 was passed twice through the short silica gel column in (n-C 6 H 14 /EtOAc, 10:1) to furnish pure 6 as crystalline solid, m.p. 125-128 C.
R f = 0.31 (EtOAc). 1 Benzyl ((rac)-1-(adamantan-1-yl)but-3-en-1-yl)carbamate (rac-5).
To a flask charged with a solution of sulfonamide 7 (50 mg, 0.15 mmol) in DCM (0.3 ml) TfOH (0.11 g/0.066 ml, 0.75 mmol, 5 equiv.) was added and the mixture was heated on water bath at 50 C for 10 min. The progress of the reaction was monitored by TLC (n-C 6 H 14 /EtOAc, 4:1). After the removal of sulfone group was completed the mixture was diluted with Et 2 O (5 ml) followed by the addition of 20% NaOH (2 ml To a solution of (S,R S )-4 (0.95 g, 3.07 mmol) in MeOH (5 mL) a solution of 4N HCl in dioxane (3.07 mL, 12.3 mmol) was added and the mixture was left for 2 h (TLC control). The solution was then evaporated under reduced pressure to dryness. To the solid residue were added THF (8 mL) and Et 3 N (1.55 g, 2.14 mL, 15.35 mmol), after which the suspension was stirred at reflux for 10 min followed by 
tert-Butyl ((1R)-1-(adamantan-1-yl)but-3-en-1-yl)carbamate ((R)-8).
[α] D 25 = 23. 
(4S,6R)-4-(Adamantan-1-yl)-6-(bromomethyl)-1,3-oxazinan-2-one ((4S,6R)-9a).
To a refluxed solution of NBS (0.5 g, 2.78 mmol) in DCM (8 mL) was added a solution of (S)-8 (0.5 g, 1.64 mmol) in DCM (3 mL). The reaction mixture was refluxed for 2 h (TLC control), then evaporated under reduced pressure. To the residue Et 2 O (10 mL) and 5% NaOH solution (8 mL) were added and the mixture was vigorously stirred for 10 min. The organic layer was separated, dried over K 2 CO 3 and evaporated and the residue was subjected to flash chromatography on SiO 2 (n- 
(4R,6S)-4-(Adamantan-1-yl)-6-(bromomethyl)-1,3-oxazinan-2-one ((4R,6S)-9a).
[α] D 25 = 12. 
(4S,6R)-4-(1-Adamantyl)-6-(bromomethyl)-5,6-dihydro-4H-1,3-oxazin-2-yl tert-butyl ether (9b)
Ether 9b was synthesized by following procedure for 9a with exception of chromatography purification.
Instead of purification of the residue after evaporation of the reaction mixture, its solution in EtOAc was rapidly passed through the 0.5 cm layer of silica gel on the filter funnel connected to a vacuum line and washed in EtOAc. EtOAc was evaporated, residual oil dissolved in n-C 6 H 14 and again evaporated to remove traces of EtOAc. The resulting transparent oil consisting of isomeric bromides 9b (75%) was diluted with n-C 6 H 14 and placed in refrigerator at -25 °С for crystallization. The precipitated crystals were filtered and washed with chilled n-C 6 
(S)-4-(adamantan-1-yl)-6-methylene-1,3-oxazinan-2-one ((S)-10).
To a solution of crude mixture of the isomeric bromides 9b (0.52 g, 1.35 mmol) in THF (15 mL) at 0 °С was added tBuOK (0.19 g, 1.70 mmol). The mixture was then stirred for 1 h at ambient temperature.
The progress of the reaction was monitored by TLC (n-C 6 H 14 /EtOAc). After completion, the reaction mixture was cooled to -20 °С and quenched with AcOH (0.06 g, 0.057 mL, 1.0 mmol) in THF (2 mL). 
(4R,6R)-6-((Adamantan-1-yl)-4-hydroxypiperidin-2-one ((4R,6R)-12).
[α] D 25 = 37. 
(2R,4S)-2-(Adamantan-1-yl)piperidin-4-ol hydrochloride ((2R,4S)-13).
To a solution of (4R,6R)-12 (130 mg, 0.52 mmol) in THF (8 mL) was added at 0 °С dropwise a solution of BH 3 *Me 2 S (79 mg, 99 μL, 1.04 mmol) in THF (2 mL). After stirring at room temperature for 2 hours the reaction mixture was cooled to 0 °С and MeOH (2 mL) was added dropwise. The solvents were evaporated under reduced pressure to dryness. To the solid residue were added DCM (20 mL) and 10% NaOH solution (10 mL), after which the emulsion was stirred for 30 min. The aqueous phase was extracted with DCM (2x10 mL 
(2S,4R)-2-(adamantan-1-yl)piperidin-4-ol hydrochloride ((2S,4R)-13)
[α] D 25 = 11.9° (C 1, MeOH 
Antiviral activity assay
We The other hydrogen atoms were placed in calculated positions and refined within riding model with fixed isotropic displacement parameters [U iso (H) = 1.2U eq (C)].
In order to obtain electron density function we have used the Hansen-Coppens formalism [4] as implemented in the program package XD. [5] Input files were generated with the program InvariomTool.
[6] Topological analysis of the invariom electron density distributions obtained from X-ray diffraction data in the harmonic approximation was carried out using the WINXPRO program package. [7] Potential S11 energy density v(r) was evaluated through the Kirzhnits's approximation [8] for kinetic energy density function g(r). Accordingly, the g(r) function is described as it was repeatedly shown to give accurate estimates in many cases (those are succinctly summarized in [11] ).
Having a very simple form as 0.5v(r), it was repeatedly shown to give accurate estimates in many cases (those are succinctly summarized in [11] ). 
(S)-8 (4S,6R)-9b (S)-10 (R)-11 (4R,6R)-12
H N S O (R S )-N-((1S)-1-(adamantan-1-yl)but-3-en-1-yl)-2-H N S O (R S )-N-((1S)-1-(adamantan-1-yl)but-3-en-1-yl)-2-methylpropane-2-sulfinamide, (S,R s )-4 S23
